Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alec Zhu

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 5, 2015
Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque PathogenesisQingli Xiao, Ping Yan, Xiucui Ma, et al.
JNCI Cancer Spectrum|October 24, 2025
Individual income and race-associated differences in prostate cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Bashir Al Hussein Al Awamlh, et al.
Urology|June 16, 2023
Adoption and Outcomes of Holmium Laser Enucleation of the Prostate in the United StatesIlon C Weinstein, Xian Wu, Camilo Arenas-Gallo, et al.
European Urology Oncology|July 7, 2024
Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results RegistryAlec Zhu, James A Proudfoot, Elai Davicioni, et al.
JNCI Cancer Spectrum|October 5, 2023
Individual-level home values and cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Weichuan Dong, et al.
Clinical Genitourinary Cancer|March 21, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder CancerBrendan L Raizenne, Vadim S Koshkin, Alec Zhu, et al.
Kidney Cancer (Clifton, Va.)|July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trialsAlbert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
BMJ Open|May 19, 2023
Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplicationsJim Hu, Alec Zhu, Andrew Vickers, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Urology Practice|June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registryFrancesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 5, 2015
Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque PathogenesisQingli Xiao, Ping Yan, Xiucui Ma, et al.
JNCI Cancer Spectrum|October 24, 2025
Individual income and race-associated differences in prostate cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Bashir Al Hussein Al Awamlh, et al.
Urology|June 16, 2023
Adoption and Outcomes of Holmium Laser Enucleation of the Prostate in the United StatesIlon C Weinstein, Xian Wu, Camilo Arenas-Gallo, et al.
European Urology Oncology|July 7, 2024
Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results RegistryAlec Zhu, James A Proudfoot, Elai Davicioni, et al.
JNCI Cancer Spectrum|October 5, 2023
Individual-level home values and cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Weichuan Dong, et al.
Clinical Genitourinary Cancer|March 21, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder CancerBrendan L Raizenne, Vadim S Koshkin, Alec Zhu, et al.
Kidney Cancer (Clifton, Va.)|July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trialsAlbert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
BMJ Open|May 19, 2023
Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplicationsJim Hu, Alec Zhu, Andrew Vickers, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Urology Practice|June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registryFrancesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
Pageof 4